{"transactions":[{"id":3349901,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":153290,"kind":"person","name":"MCCABE JOHN J","position":1,"cik":"0001205535","reported_name":"MCCABE JOHN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-12-06T22:24:33.000Z","date":"2019-12-06","kind":"grant","acquired":true,"shares":16400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares shall vest on December 6, 2020, with the remainder vesting in 36 equal monthly installments thereafter."}],"balance_after":16400,"derivative":{"exercise_price":1.27,"expiration_date":"2029-12-05","underlying":"Common Stock","underlying_shares":16400},"source":{"system":"sec-edgar","filing":"0000899243-19-028706","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000089924319028706/doc4.xml","form_type":"4"}},{"id":3349900,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":153290,"kind":"person","name":"MCCABE JOHN J","position":1,"cik":"0001205535","reported_name":"MCCABE JOHN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Common Stock","published_at":"2019-12-06T22:24:33.000Z","date":"2019-12-06","kind":"grant","acquired":true,"shares":12867,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was issued Restricted Stock Units  (\"RSU\"). Each RSU represents a contingent right to receive one share of common stock. The RSUs shall vest in four (4) annual installments, with the first tranche vesting on December 6, 2020. The RSUs may be settled only by delivering shares of common stock, and thus, the grant is being reported in Table I as allowed per SEC guidance."}],"balance_after":12867,"source":{"system":"sec-edgar","filing":"0000899243-19-028706","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000089924319028706/doc4.xml","form_type":"4"}},{"id":3626509,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":153290,"kind":"person","name":"MCCABE JOHN J","position":1,"cik":"0001205535","reported_name":"MCCABE JOHN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-02-28T22:33:12.000Z","date":"2019-02-27","kind":"grant","acquired":true,"shares":24600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares shall vest on February 27, 2020, with the remainder vesting in 12 equal quarterly installments thereafter."}],"balance_after":24600,"derivative":{"exercise_price":8.53,"expiration_date":"2029-02-26","underlying":"Common Stock","underlying_shares":24600},"source":{"system":"sec-edgar","filing":"0000899243-19-005276","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000089924319005276/doc4.xml","form_type":"4"}},{"id":3996493,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":153290,"kind":"person","name":"MCCABE JOHN J","position":1,"cik":"0001205535","reported_name":"MCCABE JOHN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-03-14T20:20:27.000Z","date":"2018-03-13","kind":"grant","acquired":true,"shares":4603,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option award was issued pursuant to the resTORbio, Inc. 2018 Stock Option and Incentive Plan. 25% of the shares shall vest on March 13, 2019; and the remaining 75% shall vest in equal quarterly installments thereafter."}],"balance_after":4603,"derivative":{"exercise_price":15.45,"expiration_date":"2028-03-13","underlying":"Common Stock","underlying_shares":4603},"source":{"system":"sec-edgar","filing":"0000899243-18-007375","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000089924318007375/doc4.xml","form_type":"4"}},{"id":4358214,"issuer":{"id":74418,"kind":"organization","name":"Carisma Therapeutics Inc.","symbol":"CARM"},"owners":[{"id":153290,"kind":"person","name":"MCCABE JOHN J","position":1,"cik":"0001205535","reported_name":"MCCABE JOHN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-04-05T16:13:11.000Z","date":"2017-04-03","kind":"grant","acquired":true,"shares":14077,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"50% of the shares subject to such option shall vest on grant date with the remaining 50% of shares underlying the option to vest on the first anniversary of the grant date."}],"balance_after":14077,"derivative":{"exercise_price":2.28,"expiration_date":"2027-04-02","underlying":"Common Stock","underlying_shares":14077},"source":{"system":"sec-edgar","filing":"0001485003-17-000027","document":"wf-form4_149142317579239.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1485003/000148500317000027/wf-form4_149142317579239.xml","form_type":"4"}},{"id":4442601,"issuer":{"id":74418,"kind":"organization","name":"Carisma Therapeutics Inc.","symbol":"CARM"},"owners":[{"id":153290,"kind":"person","name":"MCCABE JOHN J","position":1,"cik":"0001205535","reported_name":"MCCABE JOHN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-02-16T17:09:48.000Z","date":"2017-02-14","kind":"sale","acquired":false,"shares":1399,"price":2.1,"value":2937.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares of common stock underlying the restricted stock units reported as disposed herein were sold by the issuer in satisfaction of tax withholding obligations associated with the vesting of such units."}],"balance_after":5930,"source":{"system":"sec-edgar","filing":"0001485003-17-000004","document":"wf-form4_148728297397095.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1485003/000148500317000004/wf-form4_148728297397095.xml","form_type":"4"}},{"id":4597142,"issuer":{"id":74418,"kind":"organization","name":"Carisma Therapeutics Inc.","symbol":"CARM"},"owners":[{"id":153290,"kind":"person","name":"MCCABE JOHN J","position":1,"cik":"0001205535","reported_name":"MCCABE JOHN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2016-09-22T16:48:30.000Z","date":"2016-09-20","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to such option shall vest on the first anniversary of the date of grant of the option and an additional 6.25% of the shares underlying the option shall vest at the end of each successive three-month period thereafter until the fourth anniversary of the date of grant of the option."}],"balance_after":100000,"derivative":{"exercise_price":3.37,"expiration_date":"2026-09-19","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001485003-16-000170","document":"wf-form4_147457729746241.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1485003/000148500316000170/wf-form4_147457729746241.xml","form_type":"4"}},{"id":4597141,"issuer":{"id":74418,"kind":"organization","name":"Carisma Therapeutics Inc.","symbol":"CARM"},"owners":[{"id":153290,"kind":"person","name":"MCCABE JOHN J","position":1,"cik":"0001205535","reported_name":"MCCABE JOHN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2016-09-22T16:48:30.000Z","date":"2016-09-20","kind":"grant","acquired":true,"shares":6664,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On February 25, 2016, the reporting person was granted an option to purchase 20,000 shares of common stock. This option vests in installments based on the achievement of certain regulatory and business milestones. The Compensation Committee of the Company determined that one of these performance milestones was met, resulting in vesting of the option with respect to 6,664 shares. The option had previously vested with respect to 13,336 shares."}],"balance_after":20000,"derivative":{"exercise_price":0.28,"exercise_date":"2016-09-20","expiration_date":"2026-02-24","underlying":"Common Stock","underlying_shares":6664},"source":{"system":"sec-edgar","filing":"0001485003-16-000170","document":"wf-form4_147457729746241.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1485003/000148500316000170/wf-form4_147457729746241.xml","form_type":"4"}}]}